PharmAthene, Inc. (PIP) belonging to the Medical sector has declined -6.82% and closed its last trading session at $0.86.
The company reported its EPS on 03/10/2017. Currently, the stock has a 1 Year Price Target of $6.
The Company got Initiated by Aegis Capital on 6-Mar-13 to Buy.
Insider Trades for PharmAthene, Inc. show that the latest trade was made on 19 Jan 2017 where Runge (Jeffrey W), the Director completed a transaction type “Buy” in which 20000 shares were traded at a price of $3.11.
1 analysts projected Price Targets for PharmAthene, Inc.. The analysts believe that the company stock price could grow as high as $6. The Low Price target projection by analysts is $6 and the Mean Price Target is $6.
PharmAthene, Inc. (PIP) has the market capitalization of $57.83 Million. The company rocked its 52-Week High of $3.5 on Jan 19, 2017 and touched its 52-Week Low of $0.47 on Feb 6, 2017.
The stock has Return on Assets (ROA) of 221.8 percent. Return on Equity (ROE) stands at 238.1% and Return on Investment (ROI) of -20.9 percent.
The stock is currently showing YTD performance of -73.59 Percent. The company has Beta Value of 3.11 and ATR value of 0.15. The Weekly and Monthly Volatility stands at 17.58% and 11.93%.